How Does NGS Benefit Gynecological Cancer Research and Treatment?
NGS enables the identification of genetic mutations and biomarkers that are critical for the early detection, diagnosis, and personalized treatment of gynecological cancers. For example, identifying mutations in the BRCA1 and BRCA2 genes can help in assessing the risk for breast and ovarian cancers. Furthermore, NGS can aid in the development of targeted therapies by revealing actionable mutations in tumors.
